Skip to main content
. Author manuscript; available in PMC: 2012 May 1.
Published in final edited form as: Neuropharmacology. 2010 Dec 25;60(6):842–851. doi: 10.1016/j.neuropharm.2010.12.024

Figure 4.

Figure 4

Effects of endocannabinoids on ghrelin-induced pCREB expression. Photomicrographs show pCREB immunoreactivity in the control (A), 200 nM ghrelin (B), 200 nM ghrelin and 20 nM R(+)-methanandamide (C), 200 nM ghrelin, 20 nM R(+)-methanandamide and 5µM AM251 (D), 200 nM ghrelin, 20 nM R(+)-methanandamide and 5 µM capsazepine (E), 200 nM ghrelin and 5 µM AM251 (F), 200 nM ghrelin and 5 µM capsazepine (G), 200 nM ghrelin and 10 µM 2-AG(H), 200 nM ghrelin, 10 µM 2-AG and 5 µM AM251 (I). The graph in J summarizes the results. The calibration in I: 30 µm.